CRISPR/Cas9 technology generated a G to C change resulting in a tryptophan to cysteine substitution at amino acid 160 (p.W160C). This corresponds to a congenital insensitivity to pain-causing variant identified in human. (J:312689)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count